Study Links Early Statin Use in Type 2 Diabetes to Lower Dementia Risk

A Danish analysis presented at ESC Congress 2026 and published in Lancet Regional Health – Europe indicates that initiating statin therapy early after a type 2 diabetes diagnosis is associated with a greater reduction in dementia risk. Patients who started statins within one year of diagnosis showed a 15% lower relative risk of dementia after 10 years compared to those who waited five years or more. This research highlights the potential importance of timely statin intervention for improving cognitive outcomes in individuals with type 2 diabetes.